Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Midatech Pharma ADR (NQ: MTP )

N/A UNCHANGED
Last Price Updated: 3:59 PM EDT, Mar 24, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Midatech Pharma ADR

< Previous 1 2 Next >
Midatech Pharma PLC Announces R&D Programme Focused on Leptomeningeal Disease
Via ACCESSWIRE
Midatech Pharma PLC Announces Results of General Meeting
Via ACCESSWIRE
Midatech Pharma PLC Announces Further re: Notice of General Meeting
Via ACCESSWIRE
Midatech Pharma PLC Announces Posting of Circular and Notice of General Meeting
Via ACCESSWIRE
Midatech Pharma PLC Announces Closing of $6.0m Private Placement & Broker Change
Via ACCESSWIRE
Midatech Pharma PLC Announces Private Placement Raising US $6.0 million
Via ACCESSWIRE
Midatech Pharma PLC Announces Result of General Meeting
Via ACCESSWIRE
Midatech Pharma PLC Announces Planned Dose Escalation in MTX-110 Phase 1 Study
Via ACCESSWIRE
Midatech Pharma PLC Announces Posting of Circular and Notice of General Meeting
Via ACCESSWIRE
Midatech Pharma PLC - First Patient Enrolled in Phase 1 Study of MTX-110
Via ACCESSWIRE
Midatech Pharma PLC Announces Receipt of NASDAQ Notice
Via ACCESSWIRE
Bioasis Technologies Inc. Mails Management Information Circular for Annual and Special Meeting of Securityholders
From Bioasis Technologies Inc.
Via GlobeNewswire
Bioasis Technologies Inc. Announces Amendments to Arrangement Agreement with Midatech Pharma plc
From Bioasis Technologies Inc.
Via GlobeNewswire
Midatech Pharma PLC Announces Closing of Offering, Revised Terms, AIM & Webinar
Via ACCESSWIRE
Bioasis Technologies Inc. Announces Merger with Midatech Pharma plc
US$10M Registered Direct Offering and PIPE to Strengthen Balance Sheet of Combined Company 
From Bioasis Technologies Inc.
Via GlobeNewswire
Midatech Pharma PLC Announces Proposed Acquisition of Bioasis Technologies Inc
Via ACCESSWIRE
Midatech Pharma PLC Announces Receipt of NASDAQ Notification
Via ACCESSWIRE
Midatech Pharma PLC Announces ADR Ratio Change
Via ACCESSWIRE
Midatech Pharma PLC Announces Interim Results for the Six Months to 30 June 2022
Via ACCESSWIRE
Midatech Pharma PLC Announces MTX110 Development for the Treatment of Glioma
Orphan Designation Granted by EMA to MTX110 Development for the Treatment of Glioma 
From Midatech Pharma PLC
Via AccessWire
Midatech Pharma PLC Announces Retirement of Chairman and Proposed New Chairman
ABINGDON, OXFORDSHIRE / ACCESSWIRE / June 10, 2022 / Midatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP), an R&D biotechnology company focused on improving the bio-delivery and biodistribution of medicines,... 
From Midatech Pharma PLC
Via AccessWire
Topics Retirement
Exposures Pension
Midatech Pharma PLC - MTX110 Study to be Presented at ISPNO 2022
ABINGDON, OXFORDSHIRE / ACCESSWIRE / June 10, 2022 / Midatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP), an R&D biotechnology company focused on improving the bio-delivery and biodistribution of medicines,... 
From Midatech Pharma PLC
Via AccessWire
Midatech Pharma PLC Announces Fast Track Designation for MTX110 Development
Fast Track Designation Granted to MTX110 Development for the Treatment of Recurrent Glioblastoma 
From Midatech Pharma PLC
Via AccessWire
Exposures Product Safety
Midatech Pharma PLC Announces Posting of Annual Report & Notice of AGM
ABINGDON, OXFORDSHIRE / ACCESSWIRE / May 24, 2022 / Midatech Pharma PLC (AIM:MTPH)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and bio-distribution of... 
From Midatech Pharma PLC
Via AccessWire
Midatech Pharma PLC Announces Results for the Year Ended 31 December 2021
ABINGDON, OXFORDSHIRE / ACCESSWIRE / April 26, 2022 / Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines,... 
From Midatech Pharma PLC
Via AccessWire
Midatech Pharma PLC Announces Receipt of NASDAQ Notice
ABINGDON, OXFORDSHIRE / ACCESSWIRE / April 14, 2022 / Midatech Pharma PLC (AIM:MTPH)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of... 
From Midatech Pharma PLC
Via AccessWire
Midatech Pharma PLC Announces R&D Collaboration with Janssen on Second Molecule
ABINGDON, UK / ACCESSWIRE / March 9, 2022 / Midatech Pharma PLC (AIM:MTPH)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, is... 
From Midatech Pharma PLC
Via AccessWire
Midatech Pharma PLC Announces Appointment of Nominated and Financial Adviser
ABINGDON, UK / ACCESSWIRE / March 8, 2022 / Midatech Pharma PLC (AIM:MTPH; NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicine, is... 
From Midatech Pharma PLC
Via AccessWire
Midatech Pharma PLC Announces IND Application for MTX110 Study in GBM Effective
Investigational New Drug Application for Study of MTX110 in Recurrent Glioblastoma (GBM) Becomes Effective ABINGDON, OXFORDSHIRE / ACCESSWIRE / December 13, 2021 / Midatech Pharma PLC... 
From Midatech Pharma PLC
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Midatech Pharma PLC Announces Notice of Interim Results
ABINGDON, OXFORDSHIRE / ACCESSWIRE / September 6, 2021 / Midatech Pharma PLC (AIM:MTPH)(Nasdaq:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of... 
From Midatech Pharma PLC
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.